PG
CMD

PEAK6 Group’s Cantel Medical Corporation CMD Stock Holding History

PEAK6 Group’s Portfolio CMD Stock Details CMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		$1.04M Buy
10,600
+3,000
+39% +$336K ﹤0.01% 1920
2018
Q1 		$847K Sell
7,600
-10,100
-57% -$1.13M ﹤0.01% 2107
2017
Q4 		$1.82M Sell
17,700
-13,100
-43% -$1.3M 0.01% 1465
2017
Q3 		$2.9M Buy
30,800
+20,900
+211% +$1.65M 0.01% 1105
2017
Q2 		$771K Sell
9,900
-3,500
-26% -$263K ﹤0.01% 2136
2017
Q1 		$1.07M Sell
13,400
-3,200
-19% -$254K 0.01% 1622
2016
Q4 		$1.31M Buy
16,600
+13,100
+374% +$1.02M 0.01% 1642
2016
Q3 		$273K Buy
+3,500
New +$254K ﹤0.01% 2890
2016
Q1 		– Sell
-28,900
Closed -$1.8M – 5257
2015
Q4 		$1.8M Buy
+28,900
New +$1.76M 0.01% 1432
2014
Q2 		– Sell
-8,000
Closed -$270K – 5318
2014
Q1 		$270K Sell
8,000
-2,700
-25% -$89.1K ﹤0.01% 3146
2013
Q4 		$363K Buy
+10,700
New +$371K ﹤0.01% 2975

Other funds holding CMD

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
BCM
Brown Capital Management Baltimore, Maryland $704M AUM 6.25% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $131B AUM 28.36% 1-Year Est. Return
DM
Diker Management New York $112M AUM 59.78% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return

PEAK6 Group's CMD Position: Q2 2017 in Review

PEAK6 Group sold out of Cantel Medical Corporation (CMD) in Q2 2017, closing a stake of 7,706 shares — an estimated $579K sold.

PEAK6 Group first reported a position in CMD in Q4 2013 and held it in 4 quarters. The position peaked at $617K in Q1 2017. 214 funds tracked by Wall St. Rank hold CMD as of Q2 2017.

  • PEAK6 Group reported no remaining Cantel Medical Corporation position as of Q2 2017 after selling out during the quarter.
  • PEAK6 Group sold 7,706 Cantel Medical Corporation shares in Q2 2017, an estimated $579K.
  • PEAK6 Group first reported a position in Cantel Medical Corporation in Q4 2013 and held it in 4 quarters.
  • PEAK6 Group's Cantel Medical Corporation position peaked at $617K in Q1 2017.
  • 214 funds tracked by Wall St. Rank held Cantel Medical Corporation as of Q2 2017.

Based on PEAK6 Group's 13F filing for Q2 2017, filed 14 Aug 2017.